Luck EE - Search Results

1

Response of murine tumors to matrix-associated cisplatin intratumoral implants.

Yu NY, Conley FK, Luck EE, Brown DM. Yu NY, et al. Among authors: luck ee. NCI Monogr. 1988;(6):137-40. NCI Monogr. 1988. PMID: 3352755

2

Improvement of differential toxicity between tumor and normal tissues using intratumoral injection with or without a slow-drug-release matrix system.

Begg AC, Bartelink H, Stewart FA, Brown DM, Luck EE. Begg AC, et al. Among authors: luck ee. NCI Monogr. 1988;(6):133-6. NCI Monogr. 1988. PMID: 3352754

3

Effects of matrix-associated chemotherapy in combination with irradiation in vivo.

Howes AE, Herman TS, Montoya VP, Luck EE, Brown DM. Howes AE, et al. Among authors: luck ee. NCI Monogr. 1988;(6):141-3. NCI Monogr. 1988. PMID: 3352756

4

Antitumor effect of intratumoral administration of fluorouracil/epinephrine injectable gel in C3H mice.

Yu NY, Orenberg EK, Luck EE, Brown DM. Yu NY, et al. Among authors: luck ee. Cancer Chemother Pharmacol. 1995;36(1):27-34. doi: 10.1007/BF00685728. Cancer Chemother Pharmacol. 1995. PMID: 7720172

5

Influence of treatment sequence on efficacy of fluorouracil and cisplatin intratumoral drug delivery in vivo.

Yu NY, Patawaran MB, Chen JY, Orenberg EK, Brown DM, Luck EE. Yu NY, et al. Among authors: luck ee. Cancer J Sci Am. 1995 Sep-Oct;1(3):215-21. Cancer J Sci Am. 1995. PMID: 9166479

6

Reduction of vinblastine neurotoxicity in mice utilizing a collagen matrix carrier.

Sutton R, Yu N, Luck E, Brown D, Conley F. Sutton R, et al. Sel Cancer Ther. 1990 Spring;6(1):35-49. doi: 10.1089/sct.1990.6.35. Sel Cancer Ther. 1990. PMID: 2188316

7

The effect of intralesional 5-fluorouracil therapeutic implant (MPI 5003) for treatment of basal cell carcinoma.

Orenberg EK, Miller BH, Greenway HT, Koperski JA, Lowe N, Rosen T, Brown DM, Inui M, Korey AG, Luck EE. Orenberg EK, et al. Among authors: luck ee. J Am Acad Dermatol. 1992 Nov;27(5 Pt 1):723-8. doi: 10.1016/0190-9622(92)70245-b. J Am Acad Dermatol. 1992. PMID: 1430394 Clinical Trial.

8

Implant delivery system: intralesional delivery of chemotherapeutic agents for treatment of spontaneous skin tumors in veterinary patients.

Orenberg EK, Luck EE, Brown DM, Kitchell BE. Orenberg EK, et al. Among authors: luck ee. Clin Dermatol. 1991 Oct-Dec;9(4):561-8. doi: 10.1016/0738-081x(91)90085-y. Clin Dermatol. 1991. PMID: 1822412 No abstract available.

9

Intralesional implant for treatment of primary oral malignant melanoma in dogs.

Kitchell BE, Brown DM, Luck EE, Woods LL, Orenberg EK, Bloch DA. Kitchell BE, et al. Among authors: luck ee. J Am Vet Med Assoc. 1994 Jan 15;204(2):229-36. J Am Vet Med Assoc. 1994. PMID: 8144382

10

Intralesional sustained-release chemotherapy with therapeutic implants for treatment of canine sun-induced squamous cell carcinoma.

Kitchell BK, Orenberg EK, Brown DM, Hutson C, Ray K, Woods L, Luck E. Kitchell BK, et al. Eur J Cancer. 1995 Nov;31A(12):2093-8. doi: 10.1016/0959-8049(95)00446-7. Eur J Cancer. 1995. PMID: 8562171

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

13 results

Search Page

Filters